Virginia Cancer Specialists Initiates First Radiopharmaceutical Clinical Trial of Its Kind, Promising New Hope for Patients [Yahoo! Finance]
McKesson Corporation (MCK)
Last mckesson corporation earnings: 2/4 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.mckesson.com
Company Research
Source: Yahoo! Finance
invest in advancing cancer care through groundbreaking research, innovative solutions, and transformative education and leadership. FAIRFAX, Va. Nov. 13, 2024 /PRNewswire/ -- Virginia Cancer Specialists, the largest private cancer practice in Northern Virginia and a leader in radiopharmaceutical treatments, recently announced the initiation of the first radiopharmaceutical clinical trial of its kind, marking a significant milestone in cancer care. Radiopharmaceuticals are a specialized class of drugs that contain and deliver small amounts of radioactive material that can help diagnose and treat various cancer cells. They are designed to specifically find and attach to cancer cells all while minimizing damage to healthy tissue. Once attached, they release radiation that destroys the cancer cells. "Among the benefits of radiopharmaceuticals is the ability to precisely target cancer cells while minimizing damage to healthy tissues. Our approach can help shrink the cancer, slow its gr
Show less
Read more
Impact Snapshot
Event Time:
MCK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MCK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MCK alerts
High impacting McKesson Corporation news events
Weekly update
A roundup of the hottest topics
MCK
News
- McKesson Co. (NYSE: MCK) is now covered by analysts at Mizuho. They set a "neutral" rating and a $630.00 price target on the stock.MarketBeat
- Here's Why McKesson Corporation (MCK) was Down 15.2% in Q3 [Yahoo! Finance]Yahoo! Finance
- Virginia Cancer Specialists Earns Full Accreditation from NCODA's Center of Excellence Medically Integrated Pharmacy Program [Yahoo! Finance]Yahoo! Finance
- Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]Yahoo! Finance
- McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]Yahoo! Finance
MCK
Earnings
- 11/6/24 - Beat
MCK
Sec Filings
- 11/7/24 - Form 10-Q
- 11/6/24 - Form 8-K
- 9/10/24 - Form 8-K
- MCK's page on the SEC website